A plasma protein corona enhances the biocompatibility of Au@Fe3O4 Janus particles

Biomaterials

Volumn 68, Issue , 2015, Pages 77-88

  Landgraf, Lisa ^a   Christner, Carolin ^a   Storck, Wiebke ^b   Schick, Isabel ^c   Krumbein, Ines ^a   Dähring, Heidi ^a   Haedicke, Katja ^a   Heinz Herrmann, Karl ^a   Teichgräber, Ulf ^a   Reichenbach, Jürgen R ^a   Tremel, Wolfgang ^c   Tenzer, Stefan ^b   Hilger, Ingrid ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

In vivo imaging; Janus particles; Nanomedicine; Nanotoxicity; Protein corona

Indexed keywords

BIOCOMPATIBILITY; IRON OXIDES; MEDICAL NANOTECHNOLOGY; PLASMA STABILITY; PROTEINS; SILICA; SPHERES;

COLLOIDAL PROPERTIES; COLLOIDAL STABILITY; IN-VIVO IMAGING; JANUS PARTICLES; NANOTOXICITY; PROTEIN CORONAS; QUANTITATIVE PROTEOMIC ANALYSIS; SURFACE CHARACTERISTICS;

MAGNETITE;

GOLD NANOPARTICLE; JANUS PARTICLE; MAGNETITE NANOPARTICLE; NANOPARTICLE; PLASMA PROTEIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; BIOMATERIAL; CONTRAST MEDIUM; GOLD; NANOCAPSULE;

ADHESION; ADSORPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BIOCOMPATIBILITY; CELL VIABILITY; CIRCULATION TIME; COLLOID; COMPLEMENT SYSTEM; FEMALE; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VIVO STUDY; INTERNALIZATION; ISOELECTRIC POINT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CORONA; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS; PROTON TRANSPORT; SURFACE PROPERTY; ZETA POTENTIAL; ANIMAL; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; ENDOTHELIUM CELL; MULTIMODAL IMAGING; PARTICLE SIZE; PROCEDURES; SYNTHESIS; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

ADSORPTION; ANIMALS; BLOOD PROTEINS; COATED MATERIALS, BIOCOMPATIBLE; CONTRAST MEDIA; ENDOTHELIAL CELLS; GOLD; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MULTIMODAL IMAGING; NANOCAPSULES; PARTICLE SIZE; SURFACE PROPERTIES; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84939602873     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.07.049     Document Type: Article

References (77)

1. Fujimoto T., Ichikawa H., Akisue T., Fujita I., Kishimoto K., et al. Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy. Appl. Radiat. Isot. 2009, 7-8:S355-S358.
2. Boyer D., Tamarat P., Maali A., Lounis B., Orrit M. Photothermal imaging of nanometer-sized metal particles among scatterers. Science 2002, 5584:1160-1163.
3. Dickerson E.B., Dreaden E.C., Huang X.H., El-Sayed I.H., Chu H.H., et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008, 1:57-66.
4. Wu X., Ming T., Wang X., Wang P.N., Wang J.F., et al. High-photoluminescence-yield gold nanocubes: for cell imaging and photothermal therapy. Acs Nano 2010, 1:113-120.
5. Durr N.J., Larson T., Smith D.K., Korgel B.A., Sokolov K., et al. Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods. Nano Lett. 2007, 4:941-945.
6. Jans H., Huo Q. Gold nanoparticle-enabled biological and chemical detection and analysis. Chem. Soc. Rev. 2012, 7:2849-2866.
7. Taton T.A., Mirkin C.A., Letsinger R.L. Scanometric DNA array detection with nanoparticle probes. Science 2000, 5485:1757-1760.
8. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol. 2006, 939:248-253.
9. Xi D., Dong S., Meng X.X., Lu Q.H., Meng L.J., et al. Gold nanoparticles as computerized tomography (CT) contrast agents. Rsc Adv. 2012, 33:12515-12524.
10. Jun Y.W., Seo J.W., Cheon A. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc. Chem. Res. 2008, 2:179-189.
11. Kang S.S., Miao G.X., Shi S., Jia Z., Nikles D.E., et al. Enhanced magnetic properties of self-assembled FePt nanoparticles with MnO shell. J. Am. Chem. Soc. 2006, 4:1042-1043.
12. Kossatz S., Ludwig R., Dahring H., Ettelt V., Rimkus G., et al. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area. Pharm. Res. 2014 Dec, 31(12):3274-3288. Epub 2014 Jun 3. 10.1007/s11095-014-1417-0.
13. Schladt T.D., Schneider K., Schild H., Tremel W. Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment. Dalton Trans. 2011, 24:6315-6343.
14. Yoo D., Lee J.H., Shin T.H., Cheon J. Theranostic magnetic nanoparticles. Acc. Chem. Res. 2011, 10:863-874.
15. 4 Janus particles on human blood cells. Biomaterials 2014, 25:6986-6997.
16. Schick I., Lorenz S., Gehrig D., Schilmann A.M., Bauer H., et al. Multifunctional two-photon active silica-coated Au@MnO Janus particles for selective dual functionalization and imaging. J. Am. Chem. Soc. 2014, 6:2473-2483.
17. Xu C., Xie J., Ho D., Wang C., Kohler N., et al. Au-Fe3O4 dumbbell nanoparticles as dual-functional probes. Angew. Chem. Int. Ed. 2008, 1:173-176.
18. 4 nanoparticles for target-specific platin delivery. J. Am. Chem. Soc. 2009, 12. 4216-+.
19. Kirui D.K., Rey D.A., Batt C.A. Gold hybrid nanoparticles for targeted phototherapy and cancer imaging. Nanotechnology 2010, 10.
20. Chien C.C., Chen H.H., Lai S.F., Wu K.C., Cai X.Q., et al. Gold nanoparticles as high-resolution X-ray imaging contrast agents for the analysis of tumor-related micro-vasculature. J. Nanobiotechnol. 2012 Mar 12, 10:10. 10.1186/1477-3155-10-10.
21. Kubiliute R., Slektaite A., Burkanas M., Grigiene R., Rotomskis R. Gold nanoparticles as a contrast agent for X-ray imaging. Medical Physics in the Baltic States 2011, 27-30.
22. Ye F., Laurent S., Fornara A., Astolfi L., Qin J., et al. Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T2 contrast agent with tunable proton relaxivities. Contrast Media Mol. Imaging 2012, 5:460-468.
23. Yallapu M.M., Othman S.F., Curtis E.T., Gupta B.K., Jaggi M., et al. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 2011, 7:1890-1905.
24. Lee D.Y. Highly effective T2 MR contrast agent based on heparinized superparamagnetic iron oxide nanoparticles. Macromol. Res. 2011, 8:843-847.
25. Williams J.P., Southern P., Lissina A., Christian H.C., Sewell A.K., et al. Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity. Int. J. Nanomed. 2013, 2543-2554.
26. N'Guyen T.T., Duong H.T., Basuki J., Montembault V., Pascual S., et al. Functional iron oxide magnetic nanoparticles with hyperthermia-induced drug release ability by using a combination of orthogonal click reactions. Angew. Chem. Int. Ed. Engl. 2013, 52:14152-14156.
27. Mallick S., Sun I.C., Kim K., Yi D.K. Silica coated gold nanorods for imaging and photo-thermal therapy of cancer cells. J. Nanosci. Nanotechnol. 2013, 5:3223-3229.
28. Chen H.Y., Zhang X., Dai S.H., Ma Y.X., Cui S.S., et al. Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy. Theranostics 2013, 9:633-649.
29. Monopoli M.P., Aberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012, 12:779-786.
30. Tenzer S., Docter D., Kuharev J., Musyanovych A., Fetz V., et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 2013, 10. 772-U1000.
31. Thomas C.R., George S., Horst A.M., Ji Z., Miller R.J., et al. Nanomaterials in the environment: from materials to high-throughput screening to organisms. ACS Nano 2011, 1:13-20.
32. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 2009, 6:428-437.
33. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M.V., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 7:543-557.
34. Yan Y., Gause K.T., Kamphuis M.M.J., Ang C.S., O'Brien-Simpson N.M., et al. Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines. ACS Nano 2013, 12:10960-10970.
35. Blunk T., Hochstrasser D.F., Sanchez J.C., Muller B.W., Muller R.H. Colloidal carriers for intravenous drug targeting - plasma-protein adsorption patterns on surface-modified latex-particles evaluated by 2-dimensional polyacrylamide-gel electrophoresis. Electrophoresis 1993, 12:1382-1387.
36. Diederichs J.E. Plasma protein adsorption patterns on liposomes: establishment of analytical procedure. Electrophoresis 1996, 3:607-611.
37. Thode K., Luck M., Schroder W., Semmler W., Blunk T., et al. The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteins. J. Drug Target. 1997, 1:35-43.
38. Paula A.J., Araujo R.T., Martinez D.S.T., Paredes-Gamero E.J., Nader H.B., et al. Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles. Acs Appl. Mater. Interfaces 2013, 17:8387-8393.
39. Nienhaus G.U., Maffre P., Nienhaus K. Studying the Protein Corona on Nanoparticles by FCS. Fluorescence Fluctuation Spectroscopy (Ffs), Pt B 2013, 115-137.
40. Parak W.J. Charge Dependent Protein Corona and Cellular Uptake of Polymer-coated Colloidal Nanoparticles 2012, Abstracts of Papers of the American Chemical Society.
41. Tenzer S., Docter D., Rosfa S., Wlodarski A., Kuharev J., et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. Acs Nano 2011, 9:7155-7167.
42. Peng S., Lee Y.M., Wang C., Yin H.F., Dai S., et al. A facile synthesis of monodisperse Au nanoparticles and their catalysis of CO oxidation. Nano Res. 2008, 3:229-234.
43. Schick I., Lorenz S., Gehrig D., Schilmann A.M., Bauer H., et al. Multifunctional two-photon active silica-coated Au@MnO Janus particles for selective dual functionalization and imaging. J. Am. Chem. Soc. 2014, 6:2473-2483.
44. Wei Y.H., Bishop K.J.M., Kim J., Soh S., Grzybowski B.A. Making use of bond strength and steric hindrance in nanoscale "Synthesis". Angew. Chem. Int. Ed. 2009, 50:9477-9480.
45. Park J., An K.J., Hwang Y.S., Park J.G., Noh H.J., et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater. 2004, 12:891-895.
46. Schladt T.D., Graf T., Tremel W. Synthesis and characterization of monodisperse manganese oxide nanoparticles-evaluation of the nucleation and growth mechanism. Chem. Mater. 2009, 14:3183-3190.
47. 2 core/shell nanoparticles and their application for optical and magnetic resonance imaging. J. Mater. Chem. 2012, 18:9253-9262.
48. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 248-254.
49. Rabilloud T., Carpentier G., Tarroux P. Improvement and simplification of low-background silver staining of proteins by using sodium dithionite. Electrophoresis 1988, 6:288-291.
50. Distler U., Kuharev J., Navarro P., Levin Y., Schild H., et al. Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics. Nat. Methods 2014, 2. 167-+.
51. Docter D., Distler U., Storck W., Kuharev J., Wünsch D., Hahlbrock A., Knauer S.K., Tenzer S., Stauber R.H. Quantitative profiling of the protein coronas that form around nanoparticles. Nat. Protoc. 2014, 9:2030-2044.
52. Herrmann K.H., Schmidt S., Kretz A., Haenold R., Krumbein I., et al. Possibilities and limitations for high resolution small animal MRI on a clinical whole-body 3T scanner. Magnetic Reson. Mater. Phys. Biol. Med. 2012, 3:233-244.
53. Herrmann K.H., Pfeiffer N., Krumbein I., Herrmann L., Reichenbach J.R. MRI compatible small animal monitoring and trigger system for whole body scanners. Z. Fur Med. Phys. 2014, 1:55-64.
54. Kostro K., Wojcicka-Lorenowicz K., Glinski Z., Krakowski L., Wrona Z. Acute phase proteins as ligands of cells of the immune system. Med. Weter. 2002, 12:929-933.
55. Suffredini A.F., Fantuzzi G., Badolato R., Oppenheim J.J., O'Grady N.P. New insights into the biology of the acute phase response. J. Clin. Immunol. 1999, 4:203-214.
56. Ferreira V.P., Pangburn M.K., Cortes C. Complement control protein factor H: the good, the bad, and the inadequate. Mol. Immunol. 2010, 13:2187-2197.
57. Jones A.L., Hulett M.D., Parish C.R. Histidine-rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol. Cell Biol. 2005, 2:106-118.
58. Kumagai M., Sarma T.K., Cabral H., Kaida S., Sekino M., et al. Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties. Macromol. Rapid Commun. 2010, 17:1521-1528.
59. Di Corato R., Espinosa A., Lartigue L., Tharaud M., Chat S., et al. Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs. Biomaterials 2014, 24:6400-6411.
60. Lattuada M., Hatton T.A. Synthesis, properties and applications of Janus nanoparticles. Nano Today 2011, 3:286-308.
61. Safi M., Courtois J., Seigneuret M., Conjeaud H., Berret J.F. The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 2011, 35:9353-9363.
62. Walkey C.D., Olsen J.B., Song F.Y., Liu R., Guo H.B., et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. Acs Nano 2014, 3:2439-2455.
63. Huhn D., Kantner K., Geidel C., Brandholt S., De Cock I., et al. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. Acs Nano 2013, 4:3253-3263.
64. Wani A., Muthuswamy E., Savithra G.H.L., Mao G.Z., Brock S., et al. Surface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantrone. Pharm. Res. 2012, 9:2407-2418.
65. Wu W., He Q., Jiang C. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res. Lett. 2008, 11:397-415.
66. Zhang Q., Neoh K.G., Xu L.Q., Lu S.J., Kang E.T., et al. Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy. Langmuir 2014, 21:6151-6161.
67. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U. S. A. 2008, 38:14265-14270.
68. Kim T., Lee C.H., Joo S.W., Lee K. Kinetics of gold nanoparticle aggregation: experiments and modeling. J. Colloid Interface Sci. 2008, 2:238-243.
69. Mocanu A., Cernica I., Tomoaia G., Bobos L.D., Horovitz O., et al. Self-assembly characteristics of gold nanoparticles in the presence of cysteine. Colloids Surf. A Physicochem. Eng. Asp. 2009, 1-3:93-101.
70. Kuhli C., Scharrer I., Koch F., Hattenbach L.O. Recurrent retinal vein occlusion in a patient with increased plasma levels of histidine-rich glycoprotein. Am. J. Ophthalmol. 2003, 2:232-234.
71. Ahamed M., Alhadlaq H.A., Khan M.A.M., Akhtar M.J. Selective killing of cancer cells by iron oxide nanoparticles mediated through reactive oxygen species via p53 pathway. J. Nanoparticle Res. 2013, 1.
72. Ahamed M., Akhtar M.J., Siddiqui M.A., Ahmad J., Musarrat J., et al. Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells. Toxicology 2011, 2-3:101-108.
73. Yang M., Cheng K., Qi S., Liu H., Jiang Y., et al. Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials 2013, 11:2796-2806.
74. Ruiz A., Hernandez Y., Cabal C., Gonzalez E., Veintemillas-Verdaguer S., et al. Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol. Nanoscale 2013, 23:11400-11408.
75. Owens D.E., Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006, 1:93-102.
76. Shanehsazzadeh S., Oghabian M.A., Daha F.J., Amanlou M., Allen B.J. Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice. J. Radioanal. Nucl. Chem. 2013, 2:1517-1523.
77. Sempf K., Arrey T., Gelperina S., Schorge T., Meyer B., et al. Adsorption of plasma proteins on uncoated PLGA nanoparticles. Eur. J. Pharm. Biopharm. 2013, 1:53-60.